Direct Lenders Lead $2B Subordinated Debt Backing Hologic

A consortium of non‑bank lenders has assembled roughly $2B of subordinated debt tied to Blackstone and TPG's acquisition of Hologic. This $12.25bn financing package includes a second‑lien debt tranche that carries a coupon of about 5 percentage points over the floating benchmark and trades at 99 cents on the dollar. The arrangement underscores how banks and private creditors continue to share risk in marquee leveraged buyouts, with higher‑risk pieces designed to boost yields for capital providers in a rising‑rate environment.

The debt syndicate bringing this deal to life features a who’s who of global private credit: Public Sector Pension Investment Board (PSP Investments), Oaktree Capital Management, Franklin Templeton, Palmer Square Capital Management, Oak Hill Advisors, Sona Asset Management, Lord Abbett & Co. and Blackstone. These direct lenders have carved out a significant share of large‑scale LBO financing by absorbing mezzanine‑style risk for enhanced coupon income and potential exit upside. Their participation confirms a persistent shift toward private credit as a durable alternative to traditional bank facilities in structurally complex deals.

From a market perspective, the Hologic arrangement reflects a broader trend of more banks and non‑bank lenders collaborating on sizable leveraged financings. Direct lenders increasingly deploy higher‑risk slices to secure attractive yields when senior debt markets tighten or refinance windows close. In parallel, health‑tech and medical‑device platforms with robust growth trajectories continue to attract patient capital willing to tolerate elevated risk for long‑term upside, provided collateral quality and regulatory protections are solid.

Implications for the private‑credit market are notable. A growing chorus of investors is embracing higher‑yielding, subordinated tranches as core components of leveraged buyouts, diversifying risk across asset classes while offering incremental carry. For lenders, the payoffs hinge on the deal’s operating performance and the ability to manage downside protection in complex health‑care assets. For sponsors, access to a broad private‑credit coalition can augment financing certainty in a crowded debt market, albeit at a cost of higher blended funding rates. The ongoing appetite for such structures signals continuity in private‑credit‑driven buyouts and a sustained evolution of capital stacks in large‑scale LBOs.